Earth Science Tech, Inc. (OTC: ETST) reported financial and operational results for the third fiscal quarter ended December 31, 2025, demonstrating significant year-over-year growth. The company achieved revenue of $8.4 million, a 14.1% increase from the prior-year period, and gross profit of $6.4 million, representing a strong 76.3% margin. Net income jumped 341% to $910,000, while adjusted EBITDA reached $1.2 million. The results underscore the company's success in scaling operations and enhancing profitability.
The company's balance sheet also showed improvement, with total assets increasing to $8.1 million. Earth Science Tech ended the quarter with $416,000 in cash, $773,000 in working capital, and no bank debt. During the first nine months of fiscal 2026, the company repurchased and retired 3.7 million shares, reflecting management's confidence in the business and commitment to shareholder value.
Management attributed the strong performance to continued operating leverage and expansion initiatives. The company operates as a strategic holding company focused on value creation through acquisitions and operational optimization. Its wholly owned subsidiaries include RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, Earth Science Foundation, Inc., Las Villas Health Care, Inc., and DOConsultations, LLC, as well as an 80% interest in MagneChef. These entities span compounding pharmaceuticals, telemedicine, and real estate development.
For more details on the full press release, visit https://ibn.fm/emIBm. The latest news and updates relating to ETST are available in the company's newsroom at https://ibn.fm/ETST.
The results come as Earth Science Tech continues to execute its growth strategy, leveraging its diversified portfolio of operating businesses. The significant increase in net income and strong gross margin indicate effective cost management and revenue optimization. With no bank debt and a solid working capital position, the company appears well-positioned to pursue further expansion opportunities heading into calendar 2026.
